1220.40.4904 Boehringer Ingelheim Investigational Site

Hamburg

0 studies enrolling now · 1 studies all time

What they study most

Hepatitis C

Studies at this site

• Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3) — Completed